The Centers for Medicare & Medicaid Services (CMS), part of the U.S. Department of Health and Human Services (HHS), announced a new proposed reimbursement model for certain Medicare Part B drugs and biologicals (together, "drugs") on Oct. 25, 2018.
About coaadminThis author has not yet filled in any details.
So far coaadmin has created 2791 blog entries.
In January, Democrats will hold the majority in the House, dealing a crushing blow to much of the legislative agenda advanced by President Trump and Republicans on Capitol Hill.
Atrium Health, a dominant hospital system based in North Carolina, has agreed to a settlement with the Department of Justice and North Carolina's attorney general that will prohibit the system from imposing anticompetitive terms with health insurers that raise costs for consumers.
Office visits to primary care physicians (PCPs) declined 18 percent from 2012 to 2016 for adults under 65 years old with employer-sponsored health insurance, while office visits to nurse practitioners (NPs) and physician assistants (PAs) increased 129 percent.
Radiation oncologists are concerned about the possibility of mandatory participation in a radiation oncology demonstration after HHS Secretary Alex Azar indicated such a model was on the way. Ted Okon, executive director of the Community Oncology Alliance, said layering mandatory demonstrations on top of the voluntary Oncology Care Model doesn’t make much sense. The American
Good afternoon, and thank you for having me today. I want to start by taking a moment to remember Dan Best, who served as Secretary Azar’s Senior Advisor for Drug Pricing Reform. For those of you who had the privilege of getting to know Dan, you know that he brought tremendous energy and passion to
The nation’s hospitals have been merging at a rapid pace for a decade, forming powerful organizations that influence nearly every health care decision consumers make.
Walmart Inc. said it will require its employees to use certain hospitals for costly spine surgeries, an effort to weed out unnecessary procedures and lower its health-care spending.
Rep. Frank Pallone Jr. (D-N.J.), who is slated to be the next chairman of a House committee overseeing drug prices, said Wednesday that his top priorities on the issue are allowing Medicare to negotiate prices and speeding the approval of cheaper generic drugs.
Anne Marie Ciccarella is not a doctor, though she spends a great deal of time with them. She’s not a researcher, though she routinely pores over scientific papers on cancer. And even though she spent most of her career at an accounting firm, she’s getting paid by drug companies for her opinions.